EE45 Cost-Effectiveness of Venetoclax in Combination with Rituximab in Relapsed/Refractory Chroniclymphocytic Leukemia in Four Gulf Countries
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.351
https://www.valueinhealthjournal.com/article/S1098-3015(23)00451-5/fulltext
Title :
EE45 Cost-Effectiveness of Venetoclax in Combination with Rituximab in Relapsed/Refractory Chroniclymphocytic Leukemia in Four Gulf Countries
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00451-5&doi=10.1016/j.jval.2023.03.351
First page :
Section Title :
Open access? :
No
Section Order :
11735